Photopheresis for the Treatment of Lupus Erythematosus

[1]  D. Gladman,et al.  The lupus activity criteria count (LACC). , 1984, The Journal of rheumatology.

[2]  A. Rook,et al.  Extracorporeal photochemotherapy for drug-resistant pemphigus vulgaris. , 1990, Annals of internal medicine.

[3]  F. Gasparro,et al.  Rapid and sensitive analysis of 8-methoxypsoralen in plasma. , 1988, The Journal of investigative dermatology.

[4]  G. Hughes,et al.  Complement fixation by anti-dsDNA antibodies in SLE: measurement by radioimmunoassay and relationship with disease activity. , 1986, Annals of the rheumatic diseases.

[5]  M. I. Ivanova,et al.  Antinuclear antibodies in lupus erythematosus and Sjögren's syndrome: clinical and immunological investigations. , 1987, Scandinavian journal of rheumatology. Supplement.

[6]  I. Cohen.  The study and manipulation of experimental autoimmune disease using T lymphocyte lines. , 1985, The Journal of investigative dermatology.

[7]  J. Belli,et al.  Total lymphoid irradiation therapy in refractory rheumatoid arthritis. Fifteen- to forty-month followup. , 1984, Arthritis and rheumatism.

[8]  S. Muller,et al.  Development of photosensitivity and an SLE-like syndrome in a patient with psoriasis. , 1978, Archives of dermatology.

[9]  M. Gallo,et al.  Psoralens potentiate ultraviolet light-induced inhibition of epidermal growth factor binding. , 1986, Proceedings of the National Academy of Sciences of the United States of America.

[10]  H. Weiner,et al.  T-cell vaccination. , 1988, Immunology today.

[11]  R. Hoppe,et al.  Acquired immune tolerance to cadaveric renal allografts. A study of three patients treated with total lymphoid irradiation. , 1989, The New England journal of medicine.

[12]  H. Hönigsmann,et al.  Treatment of psoriatic arthritis by extracorporeal photochemotherapy , 1990, The British journal of dermatology.

[13]  I. Cohen,et al.  Vaccination against autoimmune disease with lines of autoimmune T lymphocytes. , 1983, Immunology today.

[14]  C. Cantor,et al.  Comparison of Synthetic Psoralen Derivatives and 8‐MOP in the Inhibition of Lymphocyte Proliferation a , 1985, Annals of the New York Academy of Sciences.

[15]  R. Bennett,et al.  DNA receptor dysfunction in systemic lupus erythematosus and kindred disorders. Induction by anti-DNA antibodies, antihistone antibodies, and antireceptor antibodies , 1987, The Journal of experimental medicine.

[16]  K Wolff,et al.  Treatment of cutaneous T-cell lymphoma by extracorporeal photochemotherapy. Preliminary results. , 1987, The New England journal of medicine.

[17]  I. Cohen,et al.  Vaccination against autoimmune encephalomyelitis with T-lymphocite line cells reactive against myelin basic protein , 1981, Nature.

[18]  K. Brandt,et al.  Systemic Lupus Erythematosus: Association With Psoralen-Ultraviolet-A Treatment of Psoriasis , 1979 .

[19]  C. Puglisi,et al.  Determination of 8-Methoxypsoralen, A Photoactive Compound, in Blood by High Pressure Liquid Chromatography , 1977 .

[20]  J F Fries,et al.  The 1982 revised criteria for the classification of systemic lupus erythematosus. , 1982, Arthritis and rheumatism.

[21]  D. Isenberg,et al.  SYSTEMIC LUPUS ERYTHEMATOSUS: 25 YEARS OF TREATMENT RELATED TO IMMUNOPATHOLOGY , 1983, The Lancet.

[22]  I. Cohen,et al.  Activated T lymphocytes produce a matrix-degrading heparan sulphate endoglycosidase , 1984, Nature.

[23]  C. Berger,et al.  Extracorporeal photopheresis in the treatment of AIDS-related complex: a pilot study. , 1990, Annals of internal medicine.

[24]  R. Hall,et al.  Anti-idiotypic antibodies as vaccine candidates. The immune network. , 1989, Archives of dermatology.

[25]  R. Edelson,et al.  Light-activated drugs. , 1988, Scientific American.

[26]  A. Steinberg,et al.  Increased immunoglobulin-secreting cells in the blood of patients with active systemic lupus erythematosus. , 1980, The American journal of medicine.

[27]  L. Laroche,et al.  Inhibition of autoimmune disease in a murine model of systemic lupus erythematosus induced by exposure to syngeneic photoinactivated lymphocytes. , 1990, The Journal of investigative dermatology.

[28]  R. Hoppe,et al.  Treatment of intractable lupus nephritis with total lymphoid irradiation. , 1985, Annals of internal medicine.

[29]  D. Nelson,et al.  Soluble interleukin 2 receptors are released from activated human lymphoid cells in vitro. , 1985, Journal of immunology.

[30]  J. Belli,et al.  Clinical and immunologic effects of fractionated total lymphoid irradiation in refractory rheumatoid arthritis. , 1981, The New England journal of medicine.

[31]  I. Cohen,et al.  Lines of T lymphocytes induce or vaccinate against autoimmune arthritis. , 1983, Science.

[32]  D. Wallace,et al.  A double-blind, controlled study of lymphoplasmapheresis versus sham apheresis in rheumatoid arthritis. , 1982, The New England journal of medicine.

[33]  G. Tsokos,et al.  T and B lymphocyte function in patients with lupus nephritis: correlation with renal pathology. , 1984, Clinical nephrology.

[34]  R. Washko,et al.  Treatment of autoimmune disease with extracorporeal photochemotherapy: progressive systemic sclerosis. , 1989, The Yale journal of biology and medicine.

[35]  R. Wolf,et al.  Soluble interleukin-2 receptors in systemic lupus erythematosus. , 1988, Arthritis and rheumatism.

[36]  P. Schur,et al.  IMMUNOLOGICAL STUDIES CONCERNING THE NEPHRITIS OF SYSTEMIC LUPUS ERYTHEMATOSUS , 1967, The Journal of experimental medicine.

[37]  L. Laroche,et al.  Inhibition of antiskin allograft immunity by infusions with syngeneic photoinactivated effector lymphocytes. , 1989, The Journal of investigative dermatology.

[38]  A. Giles,et al.  Plasmapheresis therapy in rheumatoid arthritis. A controlled, double-blind, crossover trial. , 1983, The New England journal of medicine.

[39]  W. Barth,et al.  Subacute cutaneous lupus erythematosus during PUVA therapy for psoriasis: case report and review of the literature. , 1989, Arthritis and rheumatism.

[40]  I. Cohen,et al.  The rapid isolation of clonable antigen‐specific T lymphocyte lines capable of mediating autoimmune encephalomyelitis , 1981, European journal of immunology.

[41]  D. Isenberg,et al.  The Importance of the Study of Monoclonal Antibodies , 1987 .

[42]  M. Liang,et al.  Reliability and validity of six systems for the clinical assessment of disease activity in systemic lupus erythematosus. , 1989, Arthritis and rheumatism.

[43]  H. Domke,et al.  Discoid lupus erythematosus possibly due to photochemotherapy. , 1979, Archives of dermatology.

[44]  J. Smolen.  Clinical and Serologic Features: Incidence and Diagnostic Approach , 1987 .

[45]  I. Cohen,et al.  Experimental autoimmune encephalomyelitis (EAE) mediated by T cell lines: process of selection of lines and characterization of the cells. , 1982, Journal of immunology.

[46]  M. Urowitz,et al.  Leucapheresis in severe rheumatoid arthritis. , 1979, Annals of the rheumatic diseases.

[47]  R. Edelson,et al.  Photopheresis for T cell mediated diseases. , 1988, Advances in dermatology.